Effect of Hyoscine butylbromide on the rate of cervical dilatation in labour. - Trial PACTR201403000779211
Access comprehensive clinical trial information for PACTR201403000779211 through Pure Global AI's free database. This Not Applicable trial is sponsored by John Imaralu; The postgraduate training committee; National postgraduate medical college of Nigeria and is currently Recruiting. The study focuses on Pregnancy and Childbirth; Other.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Pan Africa Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
John Imaralu; The postgraduate training committee; National postgraduate medical college of Nigeria
John Imaralu
Timeline & Enrollment
Not Applicable
Mar 08, 2014
Dec 23, 2014
Summary
The quest for drugs to shorten labour, make it as natural as possible, reduce pain and offer a favourable outcome for the mother and baby is on the increase.Hyoscine butylbromide is known for its antispasmodic action and has been in use for over five decades, reports about its effectiveness in the labour process are however conflicting. The objective of this study is to determine the effect of hyoscine butyl bromide on the duration and safety of labour.
ICD-10 Classifications
Data Source
Pan Africa Clinical Trials Registry
PACTR201403000779211
Non-Device Trial